Clinical Trial: Voglibose Tablets 0.2 / OD Tablets 0.2 Special Drug Use Surveillance "Long-term Use in Patients With Impaired Glucose Tolerance"

Study Status: Completed
Recruit Status: Completed
Study Type: Observational

---

Official Title: Basen Tablets 0.2 / Basen Oral Disintegrant（OD） Tablets 0.2 Special Drug Use Surveillance "Long-term Use in Patients With Impaired Glucose Tolerance&quo

Brief Summary: To determine the safety and efficacy of long-term use of Voglibose (Basen) to prevent progression to type 2 diabetes mellitus in patients with impaired glucose tolerance in the routine clinical setting.